Meeting ID: 533 706 009
US: +1 213 338 8477 or +1 669 219 2599 or +1 669 900 6833
Kenya: 0 800 733 310 (Toll Free)
Uganda: +256 206 300 097 or 0 800 113 279 (Toll Free)
South Africa: +27 87 551 7702 or +27 87 550 3946
Market viability: a neglected concept in implementation science
Andrew Kerkhoff, MD, PhD, MSc
Dr. Andrew D. Kerkhoff, MD, PhD, MSc, is an infectious disease physician, HIV primary care provider, and Assistant Professor in the Division of HIV, Infectious Diseases and Global Medicine, at Zuckerberg San Francisco General Hospital at the University of California, San Francisco. He has more than a decade of experience undertaking research based in sub-Saharan Africa that evaluates novel tools and strategies to improve the diagnosis of tuberculosis (TB), with a focus on low-cost, point-of-care assays. His current research seeks to apply implementation science methods, to improve individual- and population-level outcomes through the development and evaluation of equity-focused, efficient, effective and sustainable TB, HIV, and COVID-19 care engagement and retention strategies in the United States and Zambia.